[Pharmacological effects of fonturacetam (Actitropil) and prospects for its clinical use].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.17116\/jnevro202412408121<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zvejniece L<\/author><author>Zvejniece B<\/author><author>Videja M et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice.<\/title><secondary-title>Inflammopharmacology<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1007\/s10787-020-00705-7<\/electronic-resource-num><urls><related-urls><url>https:\/\/zenodo.org\/record\/4600985<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zvejniece L<\/author><author>Svalbe B<\/author><author>Veinberg G et al.<\/author><\/authors><\/contributors><titles><title>Investigation into stereoselective pharmacological activity of phenotropil.<\/title><secondary-title>Basic & clinical pharmacology & toxicology<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1111\/j.1742-7843.2011.00742.x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tiurenkov IN<\/author><author>Samotrueva MA<\/author><author>Priluchny\u012d SV<\/author><\/authors><\/contributors><titles><title>[Psychomodulating activity of phenotropil in experimental hyperthyroidism].<\/title><secondary-title>Eksperimental'naia i klinicheskaia farmakologiia<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Samotrueva MA<\/author><author>Tyurenkov IN<\/author><author>Teplyi DL et al.<\/author><\/authors><\/contributors><titles><title>Psychoimmunomodulatory effect of phenotropil in animals with immune stress.<\/title><secondary-title>Bulletin of experimental biology and medicine<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1007\/s10517-011-1257-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Liubimov AV<\/author><\/authors><\/contributors><titles><title>[The use of phenotropil in vertebrobasilar insufficiency].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Medvedev VE<\/author><author>Frolova VI<\/author><author>Epifanov AV<\/author><\/authors><\/contributors><titles><title>[New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fedin AI<\/author><author>Solov'eva \u00c9I<\/author><author>Mironova OP et al.<\/author><\/authors><\/contributors><titles><title>[Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.17116\/jnevro2014114121104-111<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kim S<\/author><author>Park JH<\/author><author>Myung SW et al.<\/author><\/authors><\/contributors><titles><title>Determination of carphedon in human urine by solid-phase microextraction using capillary gas chromatography with nitrogen-phosphorus detection.<\/title><secondary-title>The Analyst<\/secondary-title><\/titles><dates><year>1999<\/year><\/dates><electronic-resource-num>10.1039\/a906027h<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tyurenkov IN<\/author><author>Samotrueva MA<\/author><author>Tsibizova AA et al.<\/author><\/authors><\/contributors><titles><title>[PHENOTROPIL AS MODULATOR OF CYTOKINE LEVEL UNDER CONDITIONS OF EXPERIMENTAL IMMUNOPATHOLOGY].<\/title><secondary-title>Eksperimental'naia i klinicheskaia farmakologiia<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Drachouv IS<\/author><author>Bykov VN<\/author><author>Seleznev AB<\/author><\/authors><\/contributors><titles><title>[Administration of Palonosetron and Phenotropil for Prophylaxis of the N-V-D Stage of Acute Radiation Syndrome].<\/title><secondary-title>Radiatsionnaia biologiia, radioecologiia<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Koval'chuk VV<\/author><author>Skoromets AA<\/author><author>Koval'chuk IV et al.<\/author><\/authors><\/contributors><titles><title>[Efficacy of phenotropil in the rehabilitation of stroke patients].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Akhapkina VI<\/author><author>Akhapkin RV<\/author><\/authors><\/contributors><titles><title>[Identification and evaluation of the neuroleptic activity of phenotropil].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bobkov IuG<\/author><author>Morozov IS<\/author><author>Glozman OM et al.<\/author><\/authors><\/contributors><titles><title>[Pharmacological characteristics of a new phenyl analog of piracetam--4-phenylpiracetam].<\/title><secondary-title>Biulleten' eksperimental'noi biologii i meditsiny<\/secondary-title><\/titles><dates><year>1983<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Samotrueva MA<\/author><author>Tiurenkov IN<\/author><author>Teply\u012d DL et al.<\/author><\/authors><\/contributors><titles><title>[Phenotropyl succinate as the means for correction of neuroimmune disturbances under conditions of informational-physical stress].<\/title><secondary-title>Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>Gromova OA<\/author>Torshin IY<\/author><\/authors><\/contributors>[Pharmacological effects of fonturacetam (Actitropil) and prospects for its clinical use].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.17116\/jnevro202412408121<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zvejniece L<\/author><author>Zvejniece B<\/author><author>Videja M et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice.<\/title><secondary-title>Inflammopharmacology<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1007\/s10787-020-00705-7<\/electronic-resource-num><urls><related-urls><url>https:\/\/zenodo.org\/record\/4600985<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zvejniece L<\/author><author>Svalbe B<\/author><author>Veinberg G et al.<\/author><\/authors><\/contributors><titles><title>Investigation into stereoselective pharmacological activity of phenotropil.<\/title><secondary-title>Basic & clinical pharmacology & toxicology<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1111\/j.1742-7843.2011.00742.x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tiurenkov IN<\/author><author>Samotrueva MA<\/author><author>Priluchny\u012d SV<\/author><\/authors><\/contributors><titles><title>[Psychomodulating activity of phenotropil in experimental hyperthyroidism].<\/title><secondary-title>Eksperimental'naia i klinicheskaia farmakologiia<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Samotrueva MA<\/author><author>Tyurenkov IN<\/author><author>Teplyi DL et al.<\/author><\/authors><\/contributors><titles><title>Psychoimmunomodulatory effect of phenotropil in animals with immune stress.<\/title><secondary-title>Bulletin of experimental biology and medicine<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1007\/s10517-011-1257-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Liubimov AV<\/author><\/authors><\/contributors><titles><title>[The use of phenotropil in vertebrobasilar insufficiency].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Medvedev VE<\/author><author>Frolova VI<\/author><author>Epifanov AV<\/author><\/authors><\/contributors><titles><title>[New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fedin AI<\/author><author>Solov'eva \u00c9I<\/author><author>Mironova OP et al.<\/author><\/authors><\/contributors><titles><title>[Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.17116\/jnevro2014114121104-111<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kim S<\/author><author>Park JH<\/author><author>Myung SW et al.<\/author><\/authors><\/contributors><titles><title>Determination of carphedon in human urine by solid-phase microextraction using capillary gas chromatography with nitrogen-phosphorus detection.<\/title><secondary-title>The Analyst<\/secondary-title><\/titles><dates><year>1999<\/year><\/dates><electronic-resource-num>10.1039\/a906027h<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tyurenkov IN<\/author><author>Samotrueva MA<\/author><author>Tsibizova AA et al.<\/author><\/authors><\/contributors><titles><title>[PHENOTROPIL AS MODULATOR OF CYTOKINE LEVEL UNDER CONDITIONS OF EXPERIMENTAL IMMUNOPATHOLOGY].<\/title><secondary-title>Eksperimental'naia i klinicheskaia farmakologiia<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Drachouv IS<\/author><author>Bykov VN<\/author><author>Seleznev AB<\/author><\/authors><\/contributors><titles><title>[Administration of Palonosetron and Phenotropil for Prophylaxis of the N-V-D Stage of Acute Radiation Syndrome].<\/title><secondary-title>Radiatsionnaia biologiia, radioecologiia<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Koval'chuk VV<\/author><author>Skoromets AA<\/author><author>Koval'chuk IV et al.<\/author><\/authors><\/contributors><titles><title>[Efficacy of phenotropil in the rehabilitation of stroke patients].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Akhapkina VI<\/author><author>Akhapkin RV<\/author><\/authors><\/contributors><titles><title>[Identification and evaluation of the neuroleptic activity of phenotropil].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bobkov IuG<\/author><author>Morozov IS<\/author><author>Glozman OM et al.<\/author><\/authors><\/contributors><titles><title>[Pharmacological characteristics of a new phenyl analog of piracetam--4-phenylpiracetam].<\/title><secondary-title>Biulleten' eksperimental'noi biologii i meditsiny<\/secondary-title><\/titles><dates><year>1983<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Samotrueva MA<\/author><author>Tiurenkov IN<\/author><author>Teply\u012d DL et al.<\/author><\/authors><\/contributors><titles><title>[Phenotropyl succinate as the means for correction of neuroimmune disturbances under conditions of informational-physical stress].<\/title><secondary-title>Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><\/record>\n<\/records><\/xml>\n"